Investing Profile

Kristina Burow

VCInvestor
Managing Director at ARCH Venture Partners
Photo of Kristina Burow, Managing Director at ARCH Venture Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of California, Berkeley Network
251 CONNECTIONS
The University of Chicago Booth School of Business Network
46 CONNECTIONS
cb
ARCH Venture Partners Managing Director
$50K - $150.0M
$50K
33
$635.8M
CompanyStageDateRound SizeTotal Raised
Tenvie Therapeutics
Series AJan 2025$200M
$200M
Metsera
Series BNov 2024$220M
Series AApr 2024$290M
$510M
Co-investors: Nimish Shah (Venrock), Paul Berns (ARCH Venture Partners)
Autobahn Therapeutics
Series CJul 2024$100M
Series BJun 2020$76M
$180M
Mirador Therapeutics
Series AMar 2024$400M
$400M
Remix Therapeutics
Series UnknownJan 2024$60M
Series BMay 2022$70M
Series ADec 2020$65M
$210M
Co-investors: Kevin Bitterman (Atlas Venture), Michael Rome (Foresite Capital), Leon Chen (The Column Group), Peter Svennilson (The Column Group)
Magnet Biomedicine
Series ASep 2023$50M
$50M
Orbital Therapeutics
Series AApr 2023$270M
SeedSep 2022
$270M
Co-investors: Vineeta Agarwala (Andreessen Horowitz), Carol Suh (ARCH Venture Partners)
Pretzel Therapeutics
Series ASep 2022$73M
$73M
Co-investors: Alaa Halawa (Mubadala), Per Samuelsson (HealthCap), Robert Tansley (Cambridge Innovation Capital), Jay Parrish (ARCH Venture Partners), Reetika Bhardwaj (ARCH Venture Partners)
Managing Director ARCH Venture PartnersPresent
University of California, Berkeley
The University of Chicago Booth School of Business MBA